Should I take Aubagio in the morning or night?

Weight loss is reported as a common side effect of Aubagio, occurring in 1% to 10% of people in post-marketing studies, although it is not listed as a side effect in the product information. Rapid weight gain has also been reported with Aubagio but this is considered uncommon. Continue reading

Aubagio is made by Sanofi Genzyme which is the specialty care business arm of Sanofi. It is unclear where Aubagio is manufactured, as Sanofi has 69 manufacturing sites in 32 countries, but the new digital manufacturing site in Framingham, Ma, USA has been reported to make medicines for Sanofi Genzyme’s specialty care portfolio. Aubagio is a specialty medicine that may be used for the treatment of Multiple Sclerosis. Continue reading

Aubagio is unlikely to reduce fatigue associated with Multiple Sclerosis (MS). 85% of patients with MS report fatigue and 76.6% report that fatigue has a significant impact on their lives. One study found ponesimod to be superior to Aubagio at reducing fatigue as measured by The Fatigue Symptoms and Impacts Questionnaire–Relapsing Multiple Sclerosis which is a patient-reported questionnaire designed to assess fatigue-related symptoms and how they affect people with MS. The investigators found that the fatigue of ponesimod patients stabilized, while that of the Aubagio patients worsened over time. Continue reading